单位(元)申万菱信中证申万医药生物指数分级A(150283)资产负债表 |
报告期 |
2020/12/31 |
2020/6/30 |
2019/12/31 |
2019/6/30 |
资产 |
银行存款 |
24,095,956 |
33,183,342 |
33,493,543 |
33,263,073 |
结算备付金 |
26,259 |
- |
15 |
- |
存出保证金 |
56,811 |
79,018 |
38,934 |
14,934 |
交易性金融资产 |
316,999,024 |
406,988,325 |
410,630,848 |
413,585,448 |
其中:股票投资 |
316,999,024 |
406,988,325 |
410,630,848 |
413,585,448 |
基金投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
3,605,656 |
1,101,605 |
740,888 |
- |
应收利息 |
5,372 |
6,044 |
6,973 |
6,536 |
应收股利 |
- |
- |
- |
- |
应收申购款 |
290,881 |
2,298,614 |
107,121 |
88,297 |
其他资产 |
- |
- |
- |
- |
资产总计 |
345,079,959 |
443,656,948 |
445,018,322 |
446,958,288 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
- |
- |
- |
- |
应付赎回款 |
4,919,641 |
6,757,075 |
4,089,990 |
749,497 |
应付管理人报酬 |
285,981 |
329,035 |
372,763 |
351,584 |
应付托管费 |
62,916 |
72,388 |
82,008 |
77,349 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
131,266 |
190,887 |
161,974 |
87,998 |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
209,685 |
155,280 |
198,828 |
161,296 |
负债合计 |
5,609,487 |
7,504,665 |
4,905,564 |
1,427,725 |
所有者权益 |
实收基金 |
194,471,944 |
294,260,488 |
419,245,925 |
496,396,868 |
未分配利润 |
144,998,528 |
141,891,795 |
20,866,834 |
-50,866,305 |
所有者权益合计 |
339,470,472 |
436,152,283 |
440,112,758 |
445,530,563 |
负债和所有者权益总计 |
345,079,959 |
443,656,948 |
445,018,322 |
446,958,288 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。